Phase I trial of 57-57 (paquinimod) in patients with systemic lupus erythematosus.
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2011
At a glance
- Drugs Paquinimod (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- 30 Nov 2011 Results published in Arthritis and Rheumatism.
- 17 Sep 2010 New trial record
- 16 Sep 2010 An update on this trial will be presented at the UBS Global Life Sciences Conference, September 2010, according to an Active Biotech media release.